DOCU vs LAB · P/E 15, rev $2.98B vs rev $174.4M
DocuSign Inc (DOCU) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the DOCU and LAB stock pages for the full models.
Not investment advice.